Real-time enrollment status for this locally advanced or metastatic solid tumor harboring an ntrk gene fusion clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:47 AM UTC
| NCT Number | NCT04142437 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 51 sites in the US |
| Sponsor | Bayer |
| Last Updated on CT.gov | July 7, 2026 (6 days ago) |
As of July 13, 2026: Clinical trial NCT04142437 is currently recruiting participants. This clinical trial study for locally advanced or metastatic solid tumor harboring an ntrk gene fusion is actively seeking new participants at 51 locations across the United States. The study is sponsored by Bayer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04142437 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04142437 was last updated 6 days ago (July 7, 2026). HelloStudys verifies this status automatically.